187 related articles for article (PubMed ID: 34838115)
1. Impact of an enhanced screening program on the detection of non-AIDS neoplasias in patients with human immunodeficiency virus infection.
Masiá M; Padilla S; Estañ G; Portu J; Silva A; Rivero A; González-Cordón A; García-Fraile L; Martínez O; Bernal E; Galera C; Boix Martínez V; Macias J; Montero M; García-Rosado D; Vivancos-Gallego MJ; Llenas-García J; Torralba M; García JA; Agulló V; Fernández-González M; Gutiérrez F; Martínez E;
Trials; 2021 Nov; 22(1):851. PubMed ID: 34838115
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Mortality due to non-AIDS-defining cancers among people living with HIV in Spain over 18 years of follow-up.
Suárez-García I; Gutierrez F; Pérez-Molina JA; Moreno S; Aldamiz T; Valencia Ortega E; Curran A; Gutiérrez González S; Asensi V; Amador Prous C; Jarrin I; Rava M;
J Cancer Res Clin Oncol; 2023 Dec; 149(20):18161-18171. PubMed ID: 38008809
[TBL] [Abstract][Full Text] [Related]
4. Cancer burden in the HIV-infected population in the United States.
Shiels MS; Pfeiffer RM; Gail MH; Hall HI; Li J; Chaturvedi AK; Bhatia K; Uldrick TS; Yarchoan R; Goedert JJ; Engels EA
J Natl Cancer Inst; 2011 May; 103(9):753-62. PubMed ID: 21483021
[TBL] [Abstract][Full Text] [Related]
5. Cancer Incidence and Cancer Screening Practices Among a Cohort of Persons Receiving HIV Care in Washington, DC.
Spence AB; Levy ME; Monroe A; Castel A; Timpone J; Horberg M; Adams-Campbell L; Kumar P
J Community Health; 2021 Feb; 46(1):75-85. PubMed ID: 32424501
[TBL] [Abstract][Full Text] [Related]
6. Malignancy Trends in HIV-Infected Patients Over the Past 10 Years in a Single-Center Retrospective Observational Study in the United States.
Rihana N; Nanjappa S; Sullivan C; Velez AP; Tienchai N; Greene JN
Cancer Control; 2018; 25(1):1073274818797955. PubMed ID: 30185062
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and trend of AIDS-defining cancers and non-AIDS-defining cancers and their association with antiretroviral therapy among people living with HIV in South Carolina: a population-based cohort study.
Nkwonta CA; Zhang J; Chen S; Weissman S; Olatosi B; Li X
AIDS Care; 2023 May; 35(5):753-763. PubMed ID: 35578401
[No Abstract] [Full Text] [Related]
8. Screening HIV-infected patients for non-AIDS-defining malignancies.
Phillips AA; Justman JE
Curr HIV/AIDS Rep; 2009 May; 6(2):83-92. PubMed ID: 19358779
[TBL] [Abstract][Full Text] [Related]
9. Review of screening guidelines for non-AIDS-defining malignancies: evolving issues in the era of highly active antiretroviral therapy.
Tyerman Z; Aboulafia DM
AIDS Rev; 2012; 14(1):3-16. PubMed ID: 22297500
[TBL] [Abstract][Full Text] [Related]
10. Non-AIDS defining cancer (NADC) among HIV-infected patients at an oncology tertiary-care center in Mexico.
Cornejo-Juárez P; Cavildo-Jerónimo D; Volkow-Fernández P
AIDS Res Ther; 2018 Oct; 15(1):16. PubMed ID: 30368240
[TBL] [Abstract][Full Text] [Related]
11. Projected Cancer Incidence Rates and Burden of Incident Cancer Cases in HIV-Infected Adults in the United States Through 2030.
Shiels MS; Islam JY; Rosenberg PS; Hall HI; Jacobson E; Engels EA
Ann Intern Med; 2018 Jun; 168(12):866-873. PubMed ID: 29801099
[TBL] [Abstract][Full Text] [Related]
12. Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals.
Burgi A; Brodine S; Wegner S; Milazzo M; Wallace MR; Spooner K; Blazes DL; Agan BK; Armstrong A; Fraser S; Crum NF
Cancer; 2005 Oct; 104(7):1505-11. PubMed ID: 16104038
[TBL] [Abstract][Full Text] [Related]
13. HIV Infection, Immunosuppression, and Age at Diagnosis of Non-AIDS-Defining Cancers.
Shiels MS; Althoff KN; Pfeiffer RM; Achenbach CJ; Abraham AG; Castilho J; Cescon A; D'Souza G; Dubrow R; Eron JJ; Gebo K; John Gill M; Goedert JJ; Grover S; Hessol NA; Justice A; Kitahata M; Mayor A; Moore RD; Napravnik S; Novak RM; Thorne JE; Silverberg MJ; Engels EA;
Clin Infect Dis; 2017 Feb; 64(4):468-475. PubMed ID: 27940936
[TBL] [Abstract][Full Text] [Related]
14. Cancer screening in people living with HIV.
Masiá M; Gutiérrez-Ortiz de la Tabla A; Gutiérrez F
Cancer Med; 2023 Nov; 12(21):20590-20603. PubMed ID: 37877338
[TBL] [Abstract][Full Text] [Related]
15. Changing Prevalence of AIDS and Non-AIDS-Defining Cancers in an Incident Cohort of People Living with HIV over 28 Years.
Cattelan AM; Mazzitelli M; Presa N; Cozzolino C; Sasset L; Leoni D; Bragato B; Scaglione V; Baldo V; Parisi SG
Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201498
[TBL] [Abstract][Full Text] [Related]
16. Optimal monitoring strategies for guiding when to switch first-line antiretroviral therapy regimens for treatment failure in adults and adolescents living with HIV in low-resource settings.
Chang LW; Harris J; Humphreys E
Cochrane Database Syst Rev; 2010 Apr; (4):CD008494. PubMed ID: 20393969
[TBL] [Abstract][Full Text] [Related]
17. Proposal of model for personalized early adapted cancer screening in people living with HIV: experience of "Gaetano Martino" Hospital University of Messina.
Pellicanò GF; Squeri A; Ciappina G; Squeri R; Palmara VI; Parisi S; Campo I; Saitta C; Rossanese M; Di Trapani E; Mancuso S; Catalano N; Allegra A; Mancuso G; Murolo G; Bignucolo A; Restivo DA; Consolo P; Berretta M
Eur Rev Med Pharmacol Sci; 2024 Apr; 28(7):2929-2942. PubMed ID: 38639530
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
